Insight Molecular Diagnostics Inc. Operating Expenses
Insight Molecular Diagnostics Inc. (IMDX) reported Operating Expenses of $11.56 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. operating expenses for the quarter ending 2026-06-30 was $11.56M, a 13.55% increase year-over-year.
- Insight Molecular Diagnostics Inc. operating expenses for the quarter ending 2026-03-31 was $4.43M, a 45.49% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating expenses for the quarter ending 2025-12-31 was $23.93M, a 30.07% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating expenses for the quarter ending 2025-09-30 was $11.19M, a 17.53% decline year-over-year.
- Insight Molecular Diagnostics Inc. operating expenses for fiscal 2025 was $53.42M, a 13.53% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. operating expenses for fiscal 2024 was $61.78M, a 141.81% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. operating expenses for fiscal 2023 was $25.55M, a 42.10% increase from fiscal 2022.
- Insight Molecular Diagnostics Inc. operating expenses for fiscal 2022 was $17.98M, a 67.40% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.56M 10-Q · filed 2026-08-10 | $15.99M 10-Q · filed 2026-08-10 | $39.92M derived: sum of 3 quarters · filed 2026-08-10 | $51.10M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $4.43M 10-Q · filed 2026-05-13 | $28.36M derived: sum of 2 quarters · filed 2026-05-13 | $39.55M derived: sum of 3 quarters · filed 2026-05-13 | $49.73M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $23.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $35.12M derived: sum of 2 quarters · filed 2026-03-26 | $45.30M derived: sum of 3 quarters · filed 2026-08-10 | $53.42M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $11.19M 10-Q · filed 2025-11-10 | $21.37M derived: sum of 2 quarters · filed 2026-08-10 | $29.49M 10-Q · filed 2025-11-10 | $63.71M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $10.18M 10-Q · filed 2026-08-10 | $10.19M 10-Q · filed 2025-08-11 | $18.30M 10-Q · filed 2026-08-10 | $18.32M 10-Q · filed 2025-08-11 | $52.53M derived: sum of 3 quarters · filed 2026-08-10 | $66.09M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $8.12M 10-Q · filed 2026-05-13 | $42.35M derived: sum of 2 quarters · filed 2026-05-13 | $55.91M derived: sum of 3 quarters · filed 2026-05-13 | $60.59M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $34.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $47.79M derived: sum of 2 quarters · filed 2026-03-26 | $52.47M derived: sum of 3 quarters · filed 2026-03-26 | $61.78M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $13.56M 10-Q · filed 2025-11-10 | $18.25M derived: sum of 2 quarters · filed 2025-11-10 | $27.56M 10-Q · filed 2025-11-10 | $43.62M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $4.68M 10-Q · filed 2025-08-11 | $13.99M 10-Q · filed 2025-08-11 | $30.06M derived: sum of 3 quarters · filed 2025-08-11 | $36.82M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $9.31M 10-Q · filed 2025-05-12 | $9.17M 10-Q · filed 2024-05-15 | $25.37M derived: sum of 2 quarters · filed 2025-05-12 | $32.13M derived: sum of 3 quarters · filed 2025-05-12 | $40.70M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $16.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $22.82M derived: sum of 2 quarters · filed 2025-03-24 | $31.39M derived: sum of 3 quarters · filed 2025-03-24 | $25.55M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $6.76M 10-Q · filed 2024-11-12 | $15.33M derived: sum of 2 quarters · filed 2024-11-12 | $9.49M 10-Q · filed 2024-11-12 | $21.11M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $8.57M 10-Q · filed 2024-08-08 | $2.73M 10-Q · filed 2024-08-08 | $14.35M derived: sum of 3 quarters · filed 2024-08-08 | $15.78M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$5.84M 10-Q · filed 2024-05-15 | $5.78M derived: sum of 2 quarters · filed 2024-05-15 | $7.22M derived: sum of 3 quarters · filed 2024-05-15 | $8.88M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $11.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $13.06M derived: sum of 2 quarters · filed 2024-04-16 | $14.71M derived: sum of 3 quarters · filed 2024-04-16 | $17.98M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $1.44M 10-Q · filed 2023-11-09 | $8.05M 10-Q · filed 2022-11-10 | $3.09M derived: sum of 2 quarters · filed 2023-11-09 | $6.36M 10-Q · filed 2023-11-09 | $25.66M 10-Q · filed 2022-11-10 | $24.15M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $1.66M 10-Q · filed 2023-08-10 | $8.25M 10-Q · filed 2022-08-12 | $4.92M 10-Q · filed 2023-08-10 | $17.61M 10-Q · filed 2022-08-12 | $22.71M derived: sum of 3 quarters · filed 2023-08-10 | $35.45M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $3.26M 10-Q · filed 2023-05-15 | $9.36M 10-Q · filed 2022-05-12 | $21.06M derived: sum of 2 quarters · filed 2023-05-15 | $33.80M derived: sum of 3 quarters · filed 2023-05-15 | $46.97M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $17.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $30.53M derived: sum of 2 quarters · filed 2023-04-12 | $43.71M derived: sum of 3 quarters · filed 2023-04-12 | $55.15M 10-K · filed 2023-04-12 | $74.40M 10-K · filed 2022-03-11 | |||
| 2021-09-30 | $12.74M 10-Q · filed 2022-11-10 | $25.91M derived: sum of 2 quarters · filed 2022-11-10 | $37.35M 10-Q · filed 2022-11-10 | $43.41M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $13.17M 10-Q · filed 2022-08-12 | $24.61M 10-Q · filed 2022-08-12 | $30.67M derived: sum of 3 quarters · filed 2022-08-12 | $36.87M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $11.44M 10-Q · filed 2022-05-12 | $17.49M derived: sum of 2 quarters · filed 2022-05-12 | $23.69M derived: sum of 3 quarters · filed 2022-05-12 | $32.24M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $6.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $12.25M derived: sum of 2 quarters · filed 2022-03-11 | $20.80M derived: sum of 3 quarters · filed 2022-03-11 | $29.07M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $6.20M 10-Q · filed 2021-11-09 | $6.80M 10-Q · filed 2020-11-12 | $14.74M derived: sum of 2 quarters · filed 2021-11-09 | $23.02M 10-Q · filed 2021-11-09 | $24.16M 10-Q · filed 2020-11-12 | $30.71M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $8.55M 10-Q · filed 2021-08-11 | $8.91M 10-Q · filed 2020-07-29 | $16.82M 10-Q · filed 2021-08-11 | $17.36M 10-Q · filed 2020-07-29 | $24.52M derived: sum of 3 quarters · filed 2021-08-11 | $29.77M derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $8.45M 10-Q · filed 2020-05-12 | $15.97M derived: sum of 2 quarters · filed 2020-05-12 | $21.23M derived: sum of 3 quarters · filed 2020-11-12 | $26.69M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-12-31 | $7.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $12.78M derived: sum of 2 quarters · filed 2020-11-12 | $18.24M derived: sum of 3 quarters · filed 2020-11-12 | $22.24M 10-K · filed 2020-03-26 | ||||
| 2019-09-30 | $5.26M 10-Q · filed 2020-11-12 | $10.72M derived: sum of 2 quarters · filed 2020-11-12 | $14.72M 10-Q · filed 2020-11-12 | $18.76M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $5.46M 10-Q · filed 2020-07-29 | $9.46M 10-Q · filed 2020-07-29 | $13.51M derived: sum of 3 quarters · filed 2020-07-29 | $16.53M derived: sum of 4 quarters · filed 2020-07-29 | ||||
| 2019-03-31 | $4.00M 10-Q · filed 2020-05-12 | $8.04M derived: sum of 2 quarters · filed 2020-05-12 | $11.07M derived: sum of 3 quarters · filed 2020-05-12 | $15.29M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $7.07M derived: sum of 2 quarters · filed 2020-03-26 | $11.30M derived: sum of 3 quarters · filed 2020-03-26 | $15.20M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $3.02M 10-Q · filed 2019-11-14 | $7.25M derived: sum of 2 quarters · filed 2019-11-14 | $11.15M 10-Q · filed 2019-11-14 | $15.05M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $4.23M 10-Q · filed 2019-08-14 | $8.13M 10-Q · filed 2019-08-14 | $12.02M derived: sum of 3 quarters · filed 2019-08-14 | $18.86M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $3.91M 10-Q · filed 2019-05-14 | $7.80M derived: sum of 2 quarters · filed 2019-05-14 | $14.63M derived: sum of 3 quarters · filed 2019-05-14 | $18.22M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $3.89M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $10.73M derived: sum of 2 quarters · filed 2019-04-01 | $14.32M derived: sum of 3 quarters · filed 2019-04-01 | $18.85M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $6.83M 10-Q · filed 2018-11-13 | $10.42M derived: sum of 2 quarters · filed 2018-11-13 | $14.96M 10-Q · filed 2018-11-13 | $18.05M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $3.59M 10-Q · filed 2018-08-14 | $8.12M 10-Q · filed 2018-08-14 | $11.21M derived: sum of 3 quarters · filed 2018-08-14 | $13.80M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $4.53M 10-Q · filed 2018-05-15 | $7.63M derived: sum of 2 quarters · filed 2018-05-15 | $10.21M derived: sum of 3 quarters · filed 2018-05-15 | $12.74M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $5.68M derived: sum of 2 quarters · filed 2018-04-02 | $8.21M derived: sum of 3 quarters · filed 2018-04-02 | $11.14M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $2.58M 10-Q · filed 2017-11-14 | $5.11M derived: sum of 2 quarters · filed 2017-11-14 | $8.05M 10-Q · filed 2017-11-14 | $11.59M derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2016-06-30 | $2.53M 10-Q · filed 2017-08-14 | $5.46M 10-Q · filed 2017-08-14 | $9.00M derived: sum of 3 quarters · filed 2018-04-02 | $11.41M derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2016-03-31 | $2.93M 10-Q · filed 2017-04-28 | $6.47M derived: sum of 2 quarters · filed 2018-04-02 | $8.88M derived: sum of 3 quarters · filed 2018-04-02 | $10.28M derived: sum of 4 quarters · filed 2018-04-02 | ||||
| 2015-12-31 | $3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $5.95M derived: sum of 2 quarters · filed 2018-04-02 | $7.35M derived: sum of 3 quarters · filed 2018-04-02 | $8.72M 10-K · filed 2018-04-02 | ||||
| 2015-09-30 | $2.41M 10-Q · filed 2016-11-10 | $3.81M derived: sum of 2 quarters · filed 2016-11-10 | $5.18M 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | $1.41M 10-Q · filed 2016-08-11 | $2.77M 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | $1.37M 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | $4.97M 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |